{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:19:08Z","timestamp":1777637948005,"version":"3.51.4"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Learning Objectives<\/jats:title>\n                  <jats:p>After completing this course, the reader will be able to: List the indications for liver transplantation in patients with hepatobiliary malignancies.Describe the MELD and PELD system.Discuss the management and treatment algorithm of a patient with hepatobiliary malignancy.<\/jats:p>\n                  <jats:p>Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com<\/jats:p>\n                  <jats:p>Liver transplantation for hepatic malignancies has emerged from an exotic and desperate approach to a well-documented and proven treatment modality for these unfortunate patients. However, early unsatisfactory results emphasized that only a highly selected patient population would benefit from transplantation. Currently, &amp;lt;10% of all liver transplants performed are for hepatocellular cancer (HCC). There is no controversy that hepatoblastoma is an excellent indication in pediatric patients with unresectable tumors. Similarly, liver transplantation for HCC in the adult population yields good results for patients whose tumor masses do not exceed the Milan criteria. It remains to be determined whether patients with more extensive tumors can be reliably selected to benefit from the procedure. Adjunctive procedures like radiofrequency ablation, chemoembolization, or cryotherapy might be indicated to limit tumor progression for patients on waiting lists. Epitheloid hemangioendothelioma is also an appropriate indication for liver transplantation, unlike angiosarcoma. Metastatic liver disease is not an indication for liver transplantation, with the exception of cases in which the primary is a neuroendocrine tumor, for which liver transplantation can result in long-term survival and even cure in a number of patients. And finally, while gallbladder cancers are never an indication for liver transplantation, rare cases of cholangiocellular cancer might qualify if aggressive combination therapies, including chemotherapy and radiotherapy followed by OLT, are carried through. Survival in these selected patients can approach that for patients with cholestatic liver disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.10-4-269","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T21:03:24Z","timestamp":1112994204000},"page":"269-281","source":"Crossref","is-referenced-by-count":108,"title":["Liver Transplantation for Malignancy"],"prefix":"10.1093","volume":"10","author":[{"given":"Martin","family":"Hertl","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital Transplant Unit, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Benedict","family":"Cosimi","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Transplant Unit, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,4,1]]},"reference":[{"key":"2021122209334218900_R1","volume-title":"Age adjusted SEER incidence and U.S. death rates and 5-year relative survival rates","author":"National Cancer Institute"},{"key":"2021122209334218900_R2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver disease","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El-Serag","year":"1999","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R4","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1016\/S0002-9343(99)00374-5","article-title":"Natural history of hepatitis C","volume":"107","author":"Seeff","year":"1999","journal-title":"Am J Med"},{"key":"2021122209334218900_R5","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0002-9343(99)00449-0","article-title":"Introduction","volume":"107","author":"Maddrey","year":"1999","journal-title":"Am J Med"},{"key":"2021122209334218900_R6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/jlts.2003.50164","article-title":"Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4","volume":"9","author":"Wali","year":"2003","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R7","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1016\/S0002-9343(99)00376-9","article-title":"Hepatitis C virus genotypes and quasispecies","volume":"107","author":"Davis","year":"1999","journal-title":"Am J Med"},{"key":"2021122209334218900_R8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.7326\/0003-4819-125-8-199610150-00002","article-title":"Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group","volume":"125","author":"Zein","year":"1996","journal-title":"Ann Intern Med"},{"key":"2021122209334218900_R9","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(99)00373-3","article-title":"Epidemiology of hepatitis C in the United States","volume":"107","author":"Williams","year":"1999","journal-title":"Am J Med"},{"key":"2021122209334218900_R10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1056\/NEJM199903113401009","article-title":"The increasing incidence of hepatocellular carcinoma","volume":"340","author":"Ince","year":"1999","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R11","first-page":"1281","volume-title":"Diseases of the Liver","author":"Di Bisceglie","year":"1999"},{"key":"2021122209334218900_R12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM199109053251002","article-title":"Hepatocellular carcinoma in Italian patients with cirrhosis","volume":"325","author":"Colombo","year":"1991","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM199306243282502","article-title":"Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein","volume":"328","author":"Sato","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/jhep.2000.20237","article-title":"Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus\u2014an analysis of 236 consecutive patients with a single lesion","volume":"32","author":"Koike","year":"2000","journal-title":"Hepatology"},{"key":"2021122209334218900_R15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/jhep.2000.20456","article-title":"Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan","volume":"32","author":"Arii","year":"2000","journal-title":"Hepatology"},{"key":"2021122209334218900_R16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/jhep.2001.27950","article-title":"Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection","volume":"34","author":"Yamamoto","year":"2001","journal-title":"Hepatology"},{"key":"2021122209334218900_R17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular cancer","volume":"332","author":"Groupe d'Etude et de Traitement du Carcinome Heptocellulaire","year":"1995","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R18","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1067\/msy.2002.119496","article-title":"Clinicopathologic risk factors for recurrance after a curative hepatic resection for hepatocellular carcinoma","volume":"131","author":"Adachi","year":"2002","journal-title":"Surgery"},{"key":"2021122209334218900_R19","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1067\/msy.2002.119497","article-title":"A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985\u20132000","volume":"131","author":"Kanematsu","year":"2002","journal-title":"Surgery"},{"key":"2021122209334218900_R20","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1067\/msy.2002.119575","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"131","author":"Suehiro","year":"2002","journal-title":"Surgery"},{"key":"2021122209334218900_R21","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1053\/jlts.2000.19009","article-title":"Living donor liver transplantation in adults: outcome in Japan","volume":"6","author":"Todo","year":"2000","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF01659064","article-title":"Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients","volume":"15","author":"Ringe","year":"1991","journal-title":"World J Surg"},{"key":"2021122209334218900_R23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00000658-199308000-00005","article-title":"Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients","volume":"218","author":"Bismuth","year":"1993","journal-title":"Ann Surg"},{"key":"2021122209334218900_R24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF01658152","article-title":"Liver resection in cirrhotic patients: a Western experience","volume":"10","author":"Bismuth","year":"1986","journal-title":"World J Surg"},{"key":"2021122209334218900_R25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00000658-199109000-00005","article-title":"Hepatic resection versus transplantation for hepatocellular carcinoma","volume":"214","author":"Iwatsuki","year":"1991","journal-title":"Ann Surg"},{"key":"2021122209334218900_R26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00000658-199803000-00015","article-title":"Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis","volume":"227","author":"Otto","year":"1998","journal-title":"Ann Surg"},{"key":"2021122209334218900_R27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM199412083312303","article-title":"Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma","volume":"331","author":"Fan","year":"1994","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R28","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.transproceed.2003.08.015","article-title":"MELD\/PELD: one year later","volume":"35","author":"Freeman","year":"2003","journal-title":"Transpl Proc"},{"key":"2021122209334218900_R29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/jlts.2002.31749","article-title":"Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma","volume":"8","author":"Cheng","year":"2002","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R30","volume-title":"Scientific Registry of Transplant Recipients","author":"US Transplant"},{"key":"2021122209334218900_R31","author":"United Network for Organ Sharing"},{"key":"2021122209334218900_R32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"2021122209334218900_R33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/jlts.2002.35336","article-title":"The quandary over liver transplantation for hepatocellular carcinoma: the greater sin?","volume":"8","author":"Fung","year":"2002","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000658-199810000-00005","article-title":"Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome","volume":"228","author":"Klintmalm","year":"1998","journal-title":"Ann Surg"},{"key":"2021122209334218900_R35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/jlts.2002.34879","article-title":"Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-199202010-00021","article-title":"Liver transplantation for primary hepatic cancer","volume":"53","author":"Haug","year":"1992","journal-title":"Transpl Proc"},{"key":"2021122209334218900_R37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/jlts.2002.34892","article-title":"Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/jlts.2002.34923","article-title":"Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/jlts.2002.34922","article-title":"Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations","volume":"8","author":"Libbrecht","year":"2002","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1148\/radiol.2212010446","article-title":"Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT","volume":"221","author":"Lim","year":"2001","journal-title":"Radiology"},{"key":"2021122209334218900_R41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1148\/radiology.219.2.r01ma40445","article-title":"Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation","volume":"219","author":"Krinsky","year":"2001","journal-title":"Radiology"},{"key":"2021122209334218900_R42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00007890-200109150-00021","article-title":"Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis","volume":"72","author":"Cheng","year":"2001","journal-title":"Transplantation"},{"key":"2021122209334218900_R43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1091-255X(01)00024-5","article-title":"Hepatocellular carcinoma: a prime indication for living donor liver transplantation","volume":"6","author":"Gondolesi","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"2021122209334218900_R44","volume-title":"Policy Notice, OPTN\/UNOS Board of Directors, April 7, 2003","author":"The Organ Procurement and Transplantation Network"},{"key":"2021122209334218900_R45","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1097\/00007890-200212270-00017","article-title":"Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosupression?","volume":"74","author":"Vivarelli","year":"2002","journal-title":"Transplantation"},{"key":"2021122209334218900_R46","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0041-1345(03)00583-9","article-title":"Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas","volume":"35","author":"De la Revilla","year":"2003","journal-title":"Transpl Proc"},{"key":"2021122209334218900_R47","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/hep.20096","article-title":"Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study","volume":"39","author":"El-Serag","year":"2004","journal-title":"Hepatology"},{"key":"2021122209334218900_R48","first-page":"299","article-title":"Results of hepatic resection and transplantation for fibrolamellar carcinoma","volume":"175","author":"Ringe","year":"1992","journal-title":"Surg Gynecol Obstet"},{"key":"2021122209334218900_R49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hep.510260412","article-title":"Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation","volume":"26","author":"Pinna","year":"1997","journal-title":"Hepatology"},{"issue":"suppl 2","key":"2021122209334218900_R50","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1053\/jlts.2000.18687","article-title":"Treatment options for other hepatic malignancies","volume":"6","author":"O'Grady","year":"2000","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R51","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"2021122209334218900_R52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis: a 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"key":"2021122209334218900_R53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","article-title":"Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma","volume":"6","author":"De Vreede","year":"2000","journal-title":"Liver Transpl"},{"issue":"suppl 2","key":"2021122209334218900_R54","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/jlts.2000.18688","article-title":"Early detection and treatment of cholangiocarcinoma","volume":"6","author":"Gores","year":"2000","journal-title":"Liver Transpl"},{"key":"2021122209334218900_R55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02307080","article-title":"Long-term results after liver transplantation for primary hepatic epitheloid hemangioendothelioma","volume":"2","author":"Madariaga","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"2021122209334218900_R56","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"},{"key":"2021122209334218900_R57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"2021122209334218900_R58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00007890-200209150-00011","article-title":"Orthotopic liver transplantation for unresectable hepatoblastoma","volume":"74","author":"Srinivasan","year":"2002","journal-title":"Transplantation"},{"key":"2021122209334218900_R59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/jpsu.2002.30264","article-title":"Strategy for hepatoblastoma management: transplant versus nontransplant surgery","volume":"37","author":"Pimpalwar","year":"2002","journal-title":"J Pediatr Surg"},{"key":"2021122209334218900_R60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199704000-00003","article-title":"Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: a 31-case French multicentric report","volume":"225","author":"Le Treut","year":"1997","journal-title":"Ann Surg"},{"key":"2021122209334218900_R61","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0041-1345(00)02586-0","article-title":"Resection versus transplantation for liver metastases from neuroendocrine tumors","volume":"33","author":"Coppa","year":"2001","journal-title":"Transplant Proc"},{"key":"2021122209334218900_R62","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000658-199704000-00002","article-title":"Liver transplantation for metastatic neuroendocrine tumors","volume":"225","author":"Lang","year":"1997","journal-title":"Ann Surg"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.10-4-269","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.10-4-269","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/10\/4\/269\/41852039\/oncolo_10_4_269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/10\/4\/269\/41852039\/oncolo_10_4_269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T16:59:55Z","timestamp":1640192395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/10\/4\/269\/6387305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4,1]]},"published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.10-4-269","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,4,1]]},"published":{"date-parts":[[2005,4,1]]}}}